Stories tagged: Motley Fool
Sun., May 21, 2017, 6 a.m.
Motley Fool: Documented profits for Iron Mountain
Iron Mountain’s (NYSE: IRM) core business is providing storage, primarily of records, and information management services to companies and government organizations. It’s also been expanding into related operations, such as …
Sun., May 14, 2017, 6:40 a.m.
Motley Fool: Whirlpool should appeal to value investors
Whirlpool (NYSE: WHR), the largest appliance manufacturer in the world, is trading at an appealing price for long-term investors. After years of growth, the company has experienced a few hiccups …
Sun., May 7, 2017, 6:30 a.m.
Motley Fool: Long-term success of mutual funds for T. Rowe Price
One of the world’s largest mutual fund companies, T. Rowe Price’s (Nasdaq: TROW) long history of excellence has made its own shares a winning investment. They have risen by about …
Sun., April 30, 2017, 4:02 a.m.
Motley Fool: Starbucks stock poised to perk up
Starbucks’ (Nasdaq: SBUX) stock has been a dud for investors over the past year. That has some wanting to exit the coffeehouse, but they will likely do well to stick …
Sun., April 23, 2017, 5:12 a.m.
Motley Fool: McKesson well positioned for profitability
It rakes in close to $200 billion per year, employs about 70,000 people and is No. 5 on the Fortune 500 list, but relatively few people have heard of McKesson …
Sun., April 16, 2017, 6 a.m.
Motley Fool: A buying opportunity in Hanesbrands
Just about every consumer has purchased something from Hanesbrands (NYSE: HBI), with its well-established brands that include Hanes, Champion, Maidenform, DIM, Bali, Playtex, Bonds, JMS/Just My Size, Nur Die/Nur Der, …
Sun., April 9, 2017, 4:30 a.m.
Motley Fool: The money mouse: Disney’s deep portfolio
With blockbuster movies like “Captain America: Civil War” and “Zootopia,” studios helped Disney rake in more than $7.5 billion in total box-office receipts last year.
Sun., April 2, 2017, midnight
The Motley Fool: Pfizer’s drug pipeline is an envious mix fighting heart disease, cancer and diabetes and others
There’s lots to like about Pfizer these days.
Sun., March 26, 2017, midnight
Motley Fool: Biotech company AbbVie offers healthy dividends
One of the best health care dividend stocks around belongs to biotech company AbbVie (NYSE: ABBV), which was spun off by Abbott Laboratories in 2013.
Sun., March 19, 2017, midnight
Motley Fool: Footwear giant Nike more than just sneakers
Shares of global footwear and apparel giant Nike (NYSE: NKE) were recently down about 13 percent from their 52-week highs. That spells opportunity more than trouble.
Sun., March 12, 2017, midnight
Motley Fool: General Electric’s bright future
Not all that long ago, General Electric (NYSE: GE) was a mega-conglomerate with its hands in a wide variety of businesses. Not anymore.
Sun., March 5, 2017, midnight
Motley Fool: Ford Motor churning out cars, profits
Ford Motor Co. (NYSE: F) has made vast improvements in the quality and attractiveness of its vehicles since the recession subsided, and now it’s churning out profits quarter after quarter. …
Sun., Feb. 26, 2017, midnight
Motley Fool: AMC down, but don’t count it out
Shares of AMC Networks (Nasdaq: AMCX), the network behind the hit show “The Walking Dead,” has acted somewhat zombielike, falling 30 percent in 2016 – and drawing the attention of …
Sun., Feb. 19, 2017, midnight
Motley Fool: Look to biotech sector for undervalued stocks
With the stock market trading near an all-time high, it’s hard to find undervalued stocks. You can find some in the biotechnology sector, though. Consider Celgene (Nasdaq: CELG).
Sun., Feb. 12, 2017, midnight
The Motley Fool: AT&T stock offers solid income
AT&T (NYSE: T) is not a perfect investment: The company has a high debt load and primarily operates in the increasingly competitive wireless industry. However, it has been around as …
Sun., Feb. 5, 2017, 5:30 a.m.
Motley Fool: Amgen a biotech blue chip
With a market value recently topping $110 billion, biotechnology titan Amgen (NASDAQ: AMGN) is a blue-chip company whose stock has been held back by bad news.
Sun., Jan. 29, 2017, 4:45 a.m.
Motley Fool: After transformation, Big Blue is generating green
After a few years of causing pain for investors, shares of IBM (NYSE: IBM) bounced back in 2016, gaining around 20 percent. The company famously spent much of the last …
Sun., Jan. 22, 2017, midnight
Alphabet’s portfolio of innovative projects could pay off over long term
In August 2015, the company formerly known as Google changed its name and corporate structure to better reflect its business model and strategy. Alphabet (Nasdaq: GOOGL, GOOG) is now a …
Sun., Jan. 15, 2017, 5:33 a.m.
Overvalued or not, Amazon.com stock value has surged
The main reason many have passed up shares of Amazon.com (Nasdaq: AMZN) is that they think the shares are overvalued. The stock has seemed overvalued for many years, though – …
Sun., Jan. 8, 2017, 5:30 a.m.
Drugmaker brings innovative drugs to market
Danish drug giant Novo Nordisk (NYSE: NVO), a kingpin in the diabetes space, disappointed Wall Street and investors following the release of its third-quarter results in late October. The company …
Sun., Jan. 1, 2017, midnight
The Motley Fool: Medical device king Medtronic warrants closer look
If you’re seeking a company that offers regular dividend increases and stable cash flow, consider medical device king Medtronic (NYSE: MDT). The company has increased its dividend for 39 years …
Sun., Dec. 25, 2016, midnight
The Motley Fool: CVS Health has a healthy future
It’s been a tough road recently for shareholders of drugstore giant CVS Health (NYSE: CVS). The company has shown moderate results in its front-of-the-store business (think shampoo, diapers, soap, chips …
Sun., Dec. 18, 2016, midnight
The Motley Fool: Apparel giant overcomes forgettable name to deliver unforgettable performance
Some of the best stocks fly under the radar of most investors. V.F. Corp. (NYSE: VFC), with an eminently forgettable name, is one such company.
Sun., Dec. 11, 2016, midnight
The Motley Fool: Calling Verizon
Over the trailing 12 months, Verizon has generated more than $28 billion in cash from operations, allowing it to reinvest in its business while leaving plenty left over for its …
Sun., Dec. 4, 2016, midnight
The Motley Fool: Skyworks Solutions takes to the skies
Skyworks Solutions is a play on the future of the Internet of Things (IoT).
Sun., Nov. 27, 2016, midnight
The Motley Fool: Winning profits with video games
Shares of video game developer Activision Blizzard (Nasdaq: ATVI) stock have averaged annual gains of nearly 21 percent over the past 20 years. The stock has been trading near its …
Sun., Nov. 20, 2016, midnight
The Motley Fool: Take a drive with affordable GM
Looking for a stock trading at a discount with a high dividend yield and future catalysts that could boost earnings? General Motors (NYSE: GM) fits the bill.
Sun., Nov. 13, 2016, midnight
The Motley Fool: A diversified GlaxoSmithKline is delivering
If you’re looking for a high-yield, low-volatility stock, consider big pharma stalwart GlaxoSmithKline.
Sun., Nov. 6, 2016, midnight
The Motley Fool: Priceline Group more than a travel group
The Motley Fool Take If you’ve been assuming that The Priceline Group (Nasdaq: PCLN) is just another “me too” travel site, you’re wrong. It actually runs a collection of industry-leading …
Sun., Oct. 30, 2016, midnight
The Motley Fool: Dividends and growth with Bristol-Myers
The Motley Fool Take Shares of Bristol-Myers Squibb (NYSE: BMY) were recently down about 30 percent from their all-time high in July. That leaves the stock more attractively priced and …